FDA Clarifies IDE Risk-Benefit Assessments

Clinical Trials Advisor
A A
The FDA has released final guidance on assessing the risks and benefits of investigational device exemption applications for human clinical studies.

To View This Article:

Login

Subscribe To Clinical Trials Advisor